 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| PBCAR 20A / Precision BioSci
Trial completion, Enrollment change: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov) - Jun 24, 2022
P1/2, N=17, Completed, Sponsor: Precision BioSciences, Inc.
Recruiting --> Completed | N=90 --> 17
- || PBCAR 20A / Precision BioSci
Trial primary completion date: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov) - Sep 13, 2020
P1/2, N=90, Recruiting, Sponsor: Precision BioSciences, Inc.
Recruiting --> Completed | N=90 --> 17 Trial primary completion date: Jul 2021 --> Mar 2022
- || PBCAR 20A / Precision BioSci
Trial completion date, Trial primary completion date: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov) - Jun 1, 2020
P1/2, N=90, Recruiting, Sponsor: Precision BioSciences, Inc.
Trial primary completion date: Jul 2021 --> Mar 2022 Trial completion date: Feb 2021 --> Feb 2023 | Trial primary completion date: Jul 2020 --> Jul 2021
- ||| PBCAR 20A / Precision BioSci
Enrollment open, Trial initiation date: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov) - Mar 17, 2020
P1/2, N=90, Recruiting, Sponsor: Precision BioSciences, Inc.
Trial completion date: Feb 2021 --> Feb 2023 | Trial primary completion date: Jul 2020 --> Jul 2021 Not yet recruiting --> Recruiting | Initiation date: Oct 2019 --> Mar 2020
- || PBCAR 20A / Precision BioSciences
IND: #PrecisionBioSciences Announces #FDA Clearance of the InvestigationalNewDrug for #PBCAR20A, a #CD20 Targeting Genome Edited #Allogeneic #CARTTherapy $DTIL https://t.co/0cYTJJp1k2 (Twitter) - Sep 17, 2019
- | PBCAR 20A / Precision BioSci
New P1/2 trial: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov) - Jul 22, 2019
P1/2, N=90, Not yet recruiting, Sponsor: Precision BioSciences, Inc.